Operation of government-owned contractor-operated (goco) r & d facilities
Ended Awarded Last action
- Contract number
- HHSN26100025
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,593,828
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 57% obligated
-
- $8,593,828.00 Current, with exercised options
- $14,982,281.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,176,785 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $64,567 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $3,187,530 | |
| Other Administrative Action | $0 | |
| Original award | $3,164,946 |
About this award
This is a delivery order contract awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., by the National Cancer Institute (NCI) to operate Government-Owned, Contractor-Operated (GOCO) research and development facilities. The contract has a ceiling value of $14,982,281.00 and an ultimate completion date of June 30, 2022. The contract is for facilities operations and maintenance, research and development activities, clinical trials management, manufacturing of therapeutics and vaccines, and specialized laboratory testing and analysis. This work is primarily performed at Leidos Biomedical Research facilities in Fort Detrick and Frederick, Maryland. Leidos Biomedical Research Inc. is an established Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing a wide range of biomedical research and facilities support services. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN26100025?
HHSN26100025 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 26, 2016.
How much is contract HHSN26100025 worth?
The government has obligated $8,593,828 on HHSN26100025. Its potential value, with all options, is $14,982,281.
Is contract HHSN26100025 an order under another contract?
Yes. HHSN26100025 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100025 competed?
The extent of competition for HHSN26100025 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award